Rapid risk assessment: Carbapenem-resistant Acinetobacter baumannii in healthcare settings – 8 December 2016
This risk assessment provides an overview of the epidemiological situation in Europe and describes a number of response options.
Rapid risk assessment: Regional outbreak of New Delhi metallo-betalactamase-producing carbapenem-resistant Enterobacteriaceae, Italy, 2018–2019
A large outbreak of New Delhi metallo-beta-lactamase (NDM)-producing carbapenem-resistant Enterobacteriaceae (CRE) has been reported from the Tuscany region in Italy. Between November 2018 and May 2019, seven Tuscan hospitals notified a total of 350 cases.
Rapid risk assessment: Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 in travellers previously hospitalised in Gran Canaria, Spain
This rapid risk assessment evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumonia e ST392 from travellers having sought medical care in Gran Canaria to healthcare facilities in their country of origin in the EU/EEA.
Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae - first update
This update of the 2016 ECDC Rapid Risk Assessment on carbapenem-resistant Enterobacteriaceae (CRE) evaluates the risk for patients and healthcare systems in EU/EEA countries due to the global spread of CRE.
Rapid risk assessment: Outbreak of VIM-producing carbapenem-resistant Pseudomonas aeruginosa linked to medical tourism to Mexico
This outbreak of Verona integron-encoded metallo-beta-lactamase-producing carbapenem-resistant Pseudomonas aeruginosa (VIM-CRPA) surgical site infections, related to invasive procedures performed in healthcare facilities in Tijuana, Baja California, Mexico, highlights the risks associated with medical tourism for patients and healthcare systems in the countries of origin.
Rapid risk assessment: Outbreak of carbapenemase-producing Enterobacterales in Lithuania, 2019
Between 1st February and 26th November 2019, 199 cases of Klebsiella pneumoniae carbapenemase (KPC)-producing carbapenem-resistant Enterobacterales (KPC-CRE) have been detected in Lithuania.
Communicable disease threats report, 17-23 May 2015, week 21
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 May 2015, and includes updates on Salmonella Enteritidis, influenza, Mycobacterium chimaera, Ebola virus, MERS, avian influenza and polio.
Communicable disease threats report, 15-21 November 2015, week 47
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 15-21 November 2015 and includes updates on Zika virus, MERS and Ebola virus disease.
Communicable disease threats report, Week 20, 10-16 May 2015
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 May 2015, and includes updates on influenza, Salmonella Enteritidis, polio, avian influenza, Ebola virus, Mycobacterium chimaera and MERS.
- Antimicrobial resistance
- Antimicrobial Resistance and Healthcare-associated Infections Programme
- Ebola haemorrhagic fever
- Emerging and Vector-borne Diseases Programme
- Healthcare-associated infections
- Influenza in humans, seasonal
- Middle East respiratory syndrome coronavirus
- Mycobacterium chimaera
- Public health threat
- Vaccine Preventable Diseases Programme
- Western Africa
Response plan to control and manage the threat of multi- and extensively drug-resistant gonorrhoea in Europe
ECDC reviewed the response plan and the 2019 update strives to further support EU Member States to develop and implement national strategies and interventions to control the threat of multidrug-resistant and extensively drug-resistant gonorrhoea in a multidisciplinary approach by outlining the suggested public health response to this threat with several vital components.